Our Work
Latham Advises Dreampath Diagnostics on Acquisition by Halma PLC
July 7, 2026
Firm represents the leading provider of automated workflow solutions for anatomical pathology laboratories in the transaction.
Latham & Watkins has advised Dreampath Diagnostics, a leading provider of automated workflow solutions for anatomical pathology laboratories, backed by Summit Partners, on its acquisition by Halma plc, a global group of life-saving technology companies.
The Latham team was led by London partner Ross Allardice and Paris partner Simon Lange, with associates Blaise Olympio and Benedict Tansey.